Literature DB >> 26494720

Pseudomyxoma peritonei diagnosed 19 years after appendicectomy.

Paula F Wrafter1, Tara Connelly2, Jody Sultan Ali Khan, William P Joyce1.   

Abstract

Pseudomyxoma peritonei (PMP) is an uncommon clinical finding describing the intraperitoneal accumulation of abundant mucinous, jelly-like material. This entity may represent a spectrum of diseases ranging from mucinous ascites, commonly associated with ruptured epithelial tumours of the appendix, to frank mucinous carcinomatosis. In cases of appendiceal origin, the patient may present with signs and symptoms of acute appendicitis, and thus careful diagnosis must be made in order to correctly and appropriately guide management. This may include a combination of surgical debulking with or without intraperitoneal or systemic chemotherapy. We present a 52-year-old woman with a 4-month history of abdominal pain and distension with a previous appendicectomy 19 years earlier. Radiological and pathological investigations diagnosed a probable PMP secondary to ruptured appendicitis many years ago. We describe her unique case, with emphasis on length of time to diagnosis and clinical management by surgical cytoreduction alone. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26494720      PMCID: PMC4620202          DOI: 10.1136/bcr-2015-211706

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  15 in total

1.  [Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies].

Authors:  Peggy Dartigues; Sylvie Isaac; Laurent Villeneuve; Olivier Glehen; Mathieu Capovilla; Anne Chevallier; Sabrina Croce; Rachid Kaci; Gerlinde Lang-Averous; Marie-Hélène Laverriere; Agnès Leroux-Broussier; Éliane Mery; Flora Poizat; Séverine Valmary-Degano; Véronique Verriele-Beurrier; François-Noël Gilly; Frédéric Bibeau
Journal:  Ann Pathol       Date:  2014-02-25       Impact factor: 0.407

2.  Pseudomyxoma peritonei.

Authors:  S Jivan; V Bahal
Journal:  Postgrad Med J       Date:  2002-03       Impact factor: 2.401

3.  Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin.

Authors:  Haney Youssef; Christopher Newman; Kandiah Chandrakumaran; Faheez Mohamed; Tom D Cecil; Brendan J Moran
Journal:  Dis Colon Rectum       Date:  2011-03       Impact factor: 4.585

Review 4.  Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis.

Authors:  Katherine McBride; David McFadden; Turner Osler
Journal:  J Surg Res       Date:  2013-01-10       Impact factor: 2.192

Review 5.  Pathologic diagnosis, origin, and natural history of pseudomyxoma peritonei.

Authors:  Rebecca Buell-Gutbrod; Katja Gwin
Journal:  Am Soc Clin Oncol Educ Book       Date:  2013

6.  Treating pseudomyxoma peritonei without heated intraperitoneal chemotherapy--a first look in New Zealand.

Authors:  Benjamin R Wheeler; Sumeet K Reddy; Diane Kenwright; John P Keating
Journal:  N Z Med J       Date:  2014-02-14

7.  Controversy and consensus on the management of patients with pseudomyxoma peritonei.

Authors:  Jason E Faris; David P Ryan
Journal:  Curr Treat Options Oncol       Date:  2013-09

8.  Appendiceal neoplasms and pseudomyxoma peritonei: a population based study.

Authors:  R M Smeenk; M L F van Velthuysen; V J Verwaal; F A N Zoetmulder
Journal:  Eur J Surg Oncol       Date:  2007-05-23       Impact factor: 4.424

9.  Concurrent MCL1 and JUN amplification in pseudomyxoma peritonei: a comprehensive genetic profiling and survival analysis.

Authors:  Terence T Sio; Aaron S Mansfield; Travis E Grotz; Rondell P Graham; Julian R Molina; Florencia G Que; Robert C Miller
Journal:  J Hum Genet       Date:  2013-12-26       Impact factor: 3.172

10.  Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin.

Authors:  Hakan Alakus; Michele L Babicky; Pradipta Ghosh; Shawn Yost; Kristen Jepsen; Yang Dai; Angelo Arias; Michael L Samuels; Evangeline S Mose; Richard B Schwab; Michael R Peterson; Andrew M Lowy; Kelly A Frazer; Olivier Harismendy
Journal:  Genome Med       Date:  2014-05-29       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.